Skip to main content
Premium Trial:

Request an Annual Quote

Scipher Medicine: John Strumbos

Scipher Medicine has appointed John Strumbos as its chief financial officer. Strumbos has over 20 years of capital markets, finance, and strategy experience in the life science industry. Prior to joining Scipher, he was VP of finance and strategy at Immunovant. Before that, he served in a variety of life science investing roles at Weiss Multi-Strategy Advisors, Buysydr, and Citadel. While working for Goldman Sachs and Morgan Stanley, he advised life science companies on capital markets deals totaling $2 billion in gross proceeds and mergers and acquisitions totaling $7 billion in enterprise value. He holds a PhD in neuroscience from Yale University, an MBA from the Yale School of Management, and a BA in neuroscience from Columbia University.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.